drugset / Trial / NCT00854451
Relation of Metabolic Rate of Omeprazole and Eradication of Helicobacter Pylori Infection
Phase 4
Completed
128 enrolled
National Taiwan University Hospital
National Science and Technology Council, Taiwan · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
The aims of this study are (1) to evaluate the prevalence rate of PM of CYP2C19 in our country; (2) to evaluate the efficacy of dual therapy with different dose of omeprazole and amoxicillin; (3) to judge the relationship of genotype of CYP2C19 and the eradication rate of dual therapy in the peptic ulcer patients; (4) to try to find out a predictor of success of dual therapy and an optimal dose of dual therapy as first-line and rescue anti-Helicobacter pylori regimen.
Timeline
- Start
- 1996-08
- Primary completion
- 1997-12
- Completion
- 1998-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Amoxicillin | Other / unclassified | 250 mg | — |
| Comparator | Amoxicillin | Other / unclassified | 500 mg | — |
| Comparator | Omeprazole | Other / unclassified | 20 mg | — |